Pediatric Neuroblastoma Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014607921
Market Monitor Global
Nov-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Pediatric Neuroblastoma Treatment in Global, including the following market information:
Global Pediatric Neuroblastoma Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Pediatric Neuroblastoma Treatment market was valued at 613.4 million in 2020 and is projected to reach US$ 739.5 million by 2027, at a CAGR of 4.8% during the forecast period.
Publisher has surveyed the Pediatric Neuroblastoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Neuroblastoma Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Pediatric Neuroblastoma Treatment Market Segment Percentages, By Type, 2020 (%)
Immunotherapy
Chemotherapy
Others

China Pediatric Neuroblastoma Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Pediatric Neuroblastoma Treatment Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others

Global Pediatric Neuroblastoma Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Pediatric Neuroblastoma Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pediatric Neuroblastoma Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Pediatric Neuroblastoma Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pediatric Neuroblastoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric Neuroblastoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric Neuroblastoma Treatment Overall Market Size
2.1 Global Pediatric Neuroblastoma Treatment Market Size: 2021 VS 2027
2.2 Global Pediatric Neuroblastoma Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pediatric Neuroblastoma Treatment Players in Global Market
3.2 Top Global Pediatric Neuroblastoma Treatment Companies Ranked by Revenue
3.3 Global Pediatric Neuroblastoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pediatric Neuroblastoma Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Pediatric Neuroblastoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric Neuroblastoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Pediatric Neuroblastoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric Neuroblastoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pediatric Neuroblastoma Treatment Market Size Markets, 2021 & 2027
4.1.2 Immunotherapy
4.1.3 Chemotherapy
4.1.4 Others
4.2 By Type - Global Pediatric Neuroblastoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Pediatric Neuroblastoma Treatment Revenue, 2016-2021
4.2.2 By Type - Global Pediatric Neuroblastoma Treatment Revenue, 2022-2027
4.2.3 By Type - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pediatric Neuroblastoma Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Pediatric Neuroblastoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Pediatric Neuroblastoma Treatment Revenue, 2016-2021
5.2.2 By Application - Global Pediatric Neuroblastoma Treatment Revenue, 2022-2027
5.2.3 By Application - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Pediatric Neuroblastoma Treatment Market Size, 2021 & 2027
6.2 By Region - Global Pediatric Neuroblastoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Pediatric Neuroblastoma Treatment Revenue, 2016-2021
6.2.2 By Region - Global Pediatric Neuroblastoma Treatment Revenue, 2022-2027
6.2.3 By Region - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Pediatric Neuroblastoma Treatment Revenue, 2016-2027
6.3.2 US Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.3.3 Canada Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.3.4 Mexico Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Pediatric Neuroblastoma Treatment Revenue, 2016-2027
6.4.2 Germany Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.4.3 France Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.4.4 U.K. Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.4.5 Italy Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.4.6 Russia Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.4.8 Benelux Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Pediatric Neuroblastoma Treatment Revenue, 2016-2027
6.5.2 China Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.5.3 Japan Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.5.4 South Korea Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.5.6 India Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Pediatric Neuroblastoma Treatment Revenue, 2016-2027
6.6.2 Brazil Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.6.3 Argentina Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue, 2016-2027
6.7.2 Turkey Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.7.3 Israel Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Pediatric Neuroblastoma Treatment Market Size, 2016-2027
6.7.5 UAE Pediatric Neuroblastoma Treatment Market Size, 2016-2027
7 Players Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Corporate Summary
7.1.2 United Therapeutics Business Overview
7.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Major Product Offerings
7.1.4 United Therapeutics Pediatric Neuroblastoma Treatment Revenue in Global (2016-2021)
7.1.5 United Therapeutics Key News
7.2 Apeiron Biologics
7.2.1 Apeiron Biologics Corporate Summary
7.2.2 Apeiron Biologics Business Overview
7.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Major Product Offerings
7.2.4 Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue in Global (2016-2021)
7.2.5 Apeiron Biologics Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Pediatric Neuroblastoma Treatment Major Product Offerings
7.3.4 Pfizer Pediatric Neuroblastoma Treatment Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Pediatric Neuroblastoma Treatment Major Product Offerings
7.4.4 Bayer Pediatric Neuroblastoma Treatment Revenue in Global (2016-2021)
7.4.5 Bayer Key News
7.5 Baxter
7.5.1 Baxter Corporate Summary
7.5.2 Baxter Business Overview
7.5.3 Baxter Pediatric Neuroblastoma Treatment Major Product Offerings
7.5.4 Baxter Pediatric Neuroblastoma Treatment Revenue in Global (2016-2021)
7.5.5 Baxter Key News
7.6 Cellectar Biosciences
7.6.1 Cellectar Biosciences Corporate Summary
7.6.2 Cellectar Biosciences Business Overview
7.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Major Product Offerings
7.6.4 Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue in Global (2016-2021)
7.6.5 Cellectar Biosciences Key News
7.7 MacroGenics
7.7.1 MacroGenics Corporate Summary
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics Pediatric Neuroblastoma Treatment Major Product Offerings
7.4.4 MacroGenics Pediatric Neuroblastoma Treatment Revenue in Global (2016-2021)
7.7.5 MacroGenics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Pediatric Neuroblastoma Treatment Market Opportunities & Trends in Global Market
Table 2. Pediatric Neuroblastoma Treatment Market Drivers in Global Market
Table 3. Pediatric Neuroblastoma Treatment Market Restraints in Global Market
Table 4. Key Players of Pediatric Neuroblastoma Treatment in Global Market
Table 5. Top Pediatric Neuroblastoma Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Pediatric Neuroblastoma Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Pediatric Neuroblastoma Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Pediatric Neuroblastoma Treatment Product Type
Table 9. List of Global Tier 1 Pediatric Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Pediatric Neuroblastoma Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Pediatric Neuroblastoma Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022-2027
Table 30. United Therapeutics Corporate Summary
Table 31. United Therapeutics Pediatric Neuroblastoma Treatment Product Offerings
Table 32. United Therapeutics Pediatric Neuroblastoma Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Apeiron Biologics Corporate Summary
Table 34. Apeiron Biologics Pediatric Neuroblastoma Treatment Product Offerings
Table 35. Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Pediatric Neuroblastoma Treatment Product Offerings
Table 38. Pfizer Pediatric Neuroblastoma Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Bayer Corporate Summary
Table 40. Bayer Pediatric Neuroblastoma Treatment Product Offerings
Table 41. Bayer Pediatric Neuroblastoma Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Baxter Corporate Summary
Table 43. Baxter Pediatric Neuroblastoma Treatment Product Offerings
Table 44. Baxter Pediatric Neuroblastoma Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Cellectar Biosciences Corporate Summary
Table 46. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product Offerings
Table 47. Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue (US$, Mn), (2016-2021)
Table 48. MacroGenics Corporate Summary
Table 49. MacroGenics Pediatric Neuroblastoma Treatment Product Offerings
Table 50. MacroGenics Pediatric Neuroblastoma Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Pediatric Neuroblastoma Treatment Segment by Type
Figure 2. Pediatric Neuroblastoma Treatment Segment by Application
Figure 3. Global Pediatric Neuroblastoma Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pediatric Neuroblastoma Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pediatric Neuroblastoma Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2020
Figure 8. By Type - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 12. US Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 24. China Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. United Therapeutics Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Pfizer Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Baxter Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. MacroGenics Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE